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Immunologic, Hematologic, and Endocrine Responses to 
Subacute and Subchronic Exposures to Graded, 
Subanesthetic Levels of Nitrous 
Oxide in CD-I Mice 
by 
Charles E. Healy, Doctor of Philosophy 
Utah State University, 1989 
Major Professor: Dr. David B. Drown 
Department: Toxicology/Biology 
Nitrous oxide (N2 0) oxidizes vitamin Bt2. disrupting deoxyribonucleic acid 
(DNA) synthesis. Occupational exposures to subanesthetic levels of the gas 
have been documented that may result in suppressed proliferative cell 
activities. Male CD-I mice were exposed to 0, 50, 500, and 5000 parts of NzO per 
million parts of air (ppm) for 6 hr/day, 5 days/week for 2 and 13 weeks. 
Splenic lymphocytes were assayed for responsiveness to mitogens and for the 
ability to produce interlcukin-2 (lL-2) . Tritiated-thymidine ([3H]-TdR) 
uptake was measured in CD-I splenic lymphocytes cultured in a mixed-
lymphocyte culture (MLC). Cytolytic cell activity was measured by 
5tchromium release assay . Antibody-mediated immunocompetency was 
determined for sheep red blood cell (SRBC)-sensitized animals by plaque-
forming cell (PFC) assay and sera anti-SRBC antibody titer. Deoxyuridine 
suppression tests (dUdRST) were performed on bone marrow cells. Serum 
adrenocorticotropic hormone and corticosterone levels were determined. 
viii 
There was significantly decreased splenic lymphocyte uptake of [3 H)-TdR by 
cells cultured with mitogenic substances and in MLC following 2-week animal 
exposures to 5000 ppm. After 13-week exposures, the animals' splenic 
lymphocytes showed decreased [3H]-TdR uptake following low Nz 0 dosing and 
nonsignificantly increased responsiveness at the higher gas exposures in 
both the blastogenic and MLC assays. Compared to control animals, the 5000-
ppm-exposure group had significantly depressed PFC activity and circulating 
anti-SRBC immunoglobulin M levels following 13-week gas exposures, and all 
three subchronic exposure groups demonstrated both decreased liver weights 
and leukopenia. Bone marrow activity at these dosing levels was dose-
responsively depressed following subchronic gas exposures. 





Since it was observed to have narcotic properties in the mid-nineteenth 
century, nitrous oxide (N20l has been used as an anesthetic and an analgesic 
gas in surgical. dental, and veterinary operatories. Its principle use today is 
as an adjuvant to other anesthetic drugs such as barbiturates (Gilman et al., 
1980). Lesser uses of N20 include its incorporation in rocket fuels and as a 
propellant in whipped-cream dispensers (Clayton and Clayton, 1978). 
Historically, N20 has been considered to be a relatively innocuous gas with 
few toxic properties unless administered in hypoxic concentrations. While 
the exact mechanism of its anesthetic effect has not been resolved to date, it 
is believed that N20 is generally not metabolized in the body and leaves by 
simple expiration following administration (Trudell, 1985) . 
Within the last 30 years, a number of studies have implicated N2 0 as a 
mediator of a variety of physiologic disorders in humans, including 
embryopathies, neuropathies, hematopathologies, and cancer, as well as some 
immunomodulations. These have been reviewed by several authors (Brodsky, 
1983, 1985; Brodsky and Cohen, 1987; Chanarin, 1982; Eger, 1985; Nunn, 1987). 
However, the precise mechanism(s) by which these disorders are produced, 
and the duration and concentration of exposure required to bring them 
about, are still unknown. In fact, there is no current United States statute 
which defines a "safe" or acceptable exposure limit for N2 0, although a 
recommended standard of 25 parts of N20 per million parts of air (ppm) based 
primarily upon behavioral performance studies by Bruce and Bach (1975, 
2 
1976) and Bruce et al. (1974) has been proposed by the National Institute for 
Occupation al Safety and Health (NTOSH) (Arc her et al., 1977). 
Due to th e interactive nat ure of th e various systems of the body, a 
su bstance that causes a disorder in either the im mune. hemopoietic, 
endocrine, or ne rvous system co uld very eas il y impact upon one or any of 
the others. For example, patients ac utel y exposed to anes thetic 
co ncentratio ns of N2 0 have sometimes presented w ith mega loblast ic 
hemopoiesis (mega loblastic anemia) and bone marrow dep ress ion (A mess e t 
al. , 1978; Amos et a/., 1982; Lassen et a/., 1956; Nunn et a/ ., 1986a; O'S ulliv an e t 
al., 1981; Skacc l et al., 1983; Sourial et al., 1985). Since immune system cells 
ultim ately arise from pluri po tent stem cells in the blood-fo rmin g system 
(Kimball , 1986), N2 0-induced hemopoie tic diso rd ers such as these may be 
indicative of a lterations within the immune system also. 
Additionally, N2 0 ex posure, like other env ironmental ex posu res (Mo njan 
and Collector, 1977) , might cause or be assoc iated with a generalized stres s of 
the central nervous sys tem (CNS), which could lead to some form of 
immunomodulation . This immunomodulation might be mediated by 
neuroendocrine alteration of biogenic amine levels (Locke an d Colligan, 
1986). Recent reviews of the interactio ns between the immune, endocrine, 
and nervous sys tems are provided by Cavagnaro e t al. (1988), Locke and 
Colligan (1986), and Solomon (1987). 
There appears to be a growing vo lume of literature describing the 
immunotoxico1o gy of various compounds to which people may be exposed 
(al though this is not so for N20). Nevertheless. immunologic endpoints arc 
not presently used as measures of toxicity in an occupational s tandards 
setting. The American Conference of Governmental Industr ial Hygienist s 
3 
(ACGIH), for instance, has recently proposed an occupational health standard 
of 50 ppm for NzO (Anonymous , 1987), but immunotoxic endpoints were not 
used in defining the chosen value. 
Because of recent advances in our understanding of the immune system 
and its relevance to the entire being, there are now those who believe (Exon 
et al. , 1986) that the time is soon coming when immunotoxicologic assessment, 
in addition to current safety assessment procedures , may be required by 
governmental regulatory agencies prior to approval of many chemicals and 
drugs. The importance of determining whether or not chemicals or drugs 
affect the immune system can be appreciated in light of their potential LO 
mediate either autoimmune disorders or simply as an immunosuppression 
that might increase susceptibility to infectious or other diseases (Dean and 
Vos, 1986; Luster and Blank, 1987; Sharma, 1984). The present study, 
therefore, was undertaken to assess whether immunomodulation occurs in a 
murine model following subacute and subchronic inhalation exposures to low 




In 1956, after administering 50% N20 for between 5 and 6 days to 6 patients 
as a tetanus treatment, Lassen et al. observed that the subjects developed 
megaloblastic anemia with decreased circu lating neutrophil and platelet 
counts. The toxic potential of N20 was not appreciated, however, until the 
publication of several epidemiologic studies in the 1970s. These studies 
indicated that chronic exposure of medical and dental personnel to trace 
concentrations of anesthetic gases result in increased incidences of 
teratogenicity and spontaneous abortion both for women directly exposed to 
the gases and for the wives of men who are exposed (Askrog and Harvald, 
1979; Cohen et al., 1971 , 1974, 1980; Knill-Janes et al .. 1972, 1975; Rosenberg 
and Kirves, 1973; Tomlin, 1979). 
A few of these studies also suggested the presence of kidney and liver 
disease and the possibility of higher cancer rates among exposed personne l. 
Some of the studies reported partially negative results, and others, while 
reporting a statistically sign ificant positive correlation between anesthetic 
gas exposure and the above-mentioned disorders, attributed their findings to 
factors such as occupational stress (Rosenberg and Kallio, 1977; Rosenberg 
and Kirves , 1973). 
Despite these differences of opinion and the technical flaws in the studies 
themselves (which disallowed drawing any firm conclusions regarding N20 
toxicity), the scientific and medical communities were nevertheless alerted to 
the need to further study N2 O's capacity to be involved in various pathologies. 
In fact, the U. S. Food and Drug Administration (FDA) issued two bulletins 
5 
(1980, 1981) warning health practitioners of the potential of the anesth etic 
gas to produce teratogenic and various other effects. The FDA has apparently 
taken no action since then, however, to regulate NzO exposures, although a 
number of animal studies (Co rbett et al., 1973; Fink et al., 1967; Lane et al., 
1980; Mazze et al., 1982, 1984, 1986; Ramazzotto et al., 1979; Shah et al., 1979; 
Vieira, 1979, Vieira et al., 1977, 1980, 1983) have generall y confirmed the 
findings of the human epidemiologic studies. 
for NzO will be discussed later. 
Occupational health standards 
BIOCHEMICAL CONSEQUENCES OF N20N!T AMIN 
B 12 INTERACTIONS 
No experiments were performed in this research to specifical ly define 
either vitamin B 12 levels or oxidation states. However, a brief description of 
previous work describing the effect N20 has on the B12 molecule is important 
to lay the groundwork 
system effects of the 
for assessing the potential hematologic and immune 
gas. Two separate studies (the first apparently 
unnoticed for seve ral years) were performed th at demonstrated N2 O's ability 
to oxidize vitamin B 12 in vitro from an active (cob(l)alamin) to an inactive 
(cob(III)alamin) form (Banks et al., 1968; Blackburn et al., 1977). Once 
formed, cob(III)alamin may then combine with other cob(I)alamins to 
produce the equally inactive cob(II)alamin. These reactions are both 
nonenzymatic and irreversible (Nunn, 1984, 1987). 
Kolhouse and Allen (1977) identified two forms of physiologically active 
vitamin B12· The first, adenosylcobalamin, is req uired by the mitochondrial 
enzyme methylmalonyl coenzyme A mutase in the conversion of 
6 
nethylmalonyl coenzyme A to succinyl coenzyme A. Methyl malonyl 
coenzyme A mutase does not appear to require the reduced form of vitamin 
£12 for its activity, however. 
The second form of vitamin Bt 2 has a methyl group substituted for the 
a:lenosyl moiety. This form of the B12 molecule is required by the cytosolic 
enzyme methionine sy nthase (sy nonym: 5-methyltetrahydrofolate-
homocysteinemethyltransferase) (MetS). A lack of active methylcobalamin 
(MeCbl), brought about by both acute and chronic N2 0 exposures, has been 
shown to result in marked decreases in MetS activity both in animals (Black 
and Tephly, 1983; Brodsky et al ., 1984; Deacon et al., 1978, 1980b, 1985; Frasca et 
a!., 1986; Hansen and Billings, 1985; Koblin et al., 1981; Kondo et al., 1981; 
Lumb et al., 1983; Nunn and Chanarin, 1985: Nunn and Sharer, 1981; 
O'Sullivan et al., 1981; Sharer et al., 1983; van Tonder et al., 1986; Viila et al., 
1986; Wilson and Home, 1986; Xue et al., 1986) and in humans (Kano et al., 
1981; Koblin et al., 1982). Methionine synthase catalyzes the conversion of 
methyltetrahydrofolate to tetrahydrofolate with the concomitant conversion 
of homocysteine to methionine (Zubay, 1983). There arc a number of possible 
consequences resulting from hinderance of this reaction, and these can be 
readily appreciated by referring to figure Il-l. The principle consequence is 
that there may be cessation of mitotic replication due to suppressed 
deoxyribonucleic acid (DNA) synthesis. This, of course, would be detrimental 
to physiologic systems such as the hemopoietic and immune systems which 
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FIG. Il-l. Various interrelated biochemical pathways that may be affected by 
nitrous oxide inactivation of methylcobalamin . 
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HEMOPOIETIC RESPONSES TO N20 EXPOSURE 
Because it oxidizes MeCbl (Banks et a/., 1968; Blackburn et a/., 1977), N2 0 is 
able to ind uce megaloblastic hemopoiesis (MH) in human bone marrow (A mos 
eta/. , 1982; Lassen eta/., 1956; Nunn et at. , 1986a; O'Sullivan eta/., 1981 ; Skacel 
eta/., 1983; Sourial et a/ ., 1985). In their studies on N2 0 mediated MH, Amess et 
at . (1978) and Sweeney et a/. (1985) measured total plasma co bal am in (Cbl) 
levels and found no difference between N20 exposu re and cont rol va lues, yet 
deoxyuridine (dUdR) suppress ion tests indicated decreased bone marrow DNA 
synthesis simila r to that seen in megaloblastic anemia patients who had 
dieta ry deficiency of ei ther vi tam in B 12 or folinic acid (Hcrben, 1985). These 
studies confirmed those of Banks et a/. (1968) and Blackburn et a/. (1977) in 
that they indicated that N2 0 produces a functional chan ge in the vitam in B t 2 
molecule w hi ch then results in the biochemical alterat ions discussed 
previously. 
Ni trous ox ide also appears 10 have deleterious synergisti c hematologic 
effects when administered to rats (Lumb et a/., 1981b; O'Leary eta/., 1985; van 
de List et a/., 1986) and humans (Nunn et a/., 1986b) already dietarily deficient 
in vitamin B t 2 o r folinic acid. Several s tudies have also indicated that B t 2 or 
folinic acid administration either prior to or following N20 ex posure ass ists in 
overcoming the hematologic effects of th e gas (A mos et a/., 1984; Deacon e t 
a/ ., 1980a; Kana et a/., 1984; O'Sullivan eta/., 1981). 
In MH, DNA synthesis is inhibited, but ribonucleic acid and protein 
sy ntheses are not; thi s results in enlargement (macrocytos is) of bo th 
erythrocytic and leukocytic precursor cells (Wintrobe, 1981 ). While 
experimental an imals exposed to N20 remain normobl as ti c (Deacon et a/., 
9 
1980a), there are biochemical manifestations , such as decreased MetS activity 
and abnorma l d UdR suppression tests, and other physiologic indications, such 
as leukopenia, that both humans and animals suffer s imilar hematologic 
insult from N20 exposure (Deacon et al., 1978, 1979, 1980a; Kripke et al ., 1977; 
McKenna et al., 1980; Nunn et al., 1976). Variability was observed when 
comparing the response rates to N2 0 of different animal species as well as of 
man, with man responding somewhat more slowly than animals (Deacon e t 
al., 1980a; Green, 1968; Green and Eastwood, 1963; Koblin et al., 1981, 1982). 
The studies mentioned above involved acute or subacute N2 0 exposures at 
concentrations ranging from 50% to 80% (500,000 ppm to 800,000 ppm of N20). 
A few articles have been published that describe the hematologic effects of 
the longer-term, lower-level concentrations of N2 0 to which medical, dental, 
and veterinary personnel are routinely exposed, but these are inconclusive 
and contradictory. 
One of these (Sweeney et al., 1985) describes the bone marrow responses of 
20 dentists exposed to N20 concentrations ranging from 159 ppm to 4600 ppm. 
Seven of the 20 dentists were exposed to N20 for 10 or more hr per week; 3 of 
these had abnormal dUdR suppression tests, and 2 o f the 3 also di splayed 
abnormal leukocyte morphologies. In study of hospital operatory 
personnel exposed to between 155 ppm and 860 ppm of N20 for unspecified 
periods of time, Salo et al. (1984) reported a slight incidence of macrocytosis 
with some hypersegmentation of neutrophils. Unlike Sweeney et al. (1985), 
these researchers felt that their findings were not indicative of significant 
hematologic insult by N2 0. Finally, Blanco and Peters ( 1983) reported the 
case of a dentist exposed to N2 0 for 4 months who presented with macrocytosis 
1 0 
and hypersegmented neutrophil s as we ll as manifestation s o f subacute 
combined degeneration of the sp inal cord. His exposure parameters were not 
given, however. In the one subchronic animal study performed to date, Rice 
et al. (1985) exposed Swiss Webster mice to between 5000 ppm and 500,000 ppm 
of N 2 0 for 4 hr per day, 5 days per week for up to 14 weeks with no lowering 
of erythrocyte or leukocyte totals or differential cell counts. 
IMMUNOTOXICOLOGIC EVALUATION OF XENOBIOTICS 
Over the last 10 to 15 years it has become increasingly apparent that the 
immune system may act as "target organ" for a number of different 
xenobiotics (Dean and Vos, 1986; Luster et a/., 1988). As such, it acts as most 
other body tissues and organs, sometimes being stimulated to overactivity and 
sometimes being depressed to lessened activity. The consequences of these 
immunomodulations may present various problems for the pe rson thus 
affected, such as increased risk of autoimmune disorder in a case of 
immunostimulation or a greater likelihood of susceptibility to contracting 
infectious disease in a case of immunosuppression. Therefore, it is important 
to determine "safe" level s of xenobiotic exposures to which people may be 
routinely exposed wi thout incurring immunotoxicologic insult. 
While a number of studies have been published that describe the effects of 
chemicals and drugs on the immune systems of both humans and various 
laboratory animal models, much work yet remains to be done both in 
defining whether various xenobiotics may be immunotoxic and in relation to 
extrapolating animal research data to the human expe rience. At present, the 
most widely accepted method for determining the immunotoxicologic 
potential of chemicals or drugs involves a tiered system of assays (Dean and 
Thurmond , 1987; Luster et at., 1988). This system is based on the assumption 
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that xenobiotics that are toxic to the immune system will manifest such 
toxicity following a bauery of tests conducted at the tier I level, weeding out 
those compounds which arc probably not toxic and, at the same time, 
pinpointing those compounds for which further research needs to be 
performed (tier II level). 
The tier I level of research (Dean and Thurmond, 1987; Luster et at., 1988) 
includes histopathologic exami nati on of various immune system organs, 
enumeration of body and organ weights and sp lenic ce llularity , routine 
hematology. and the following immunoassays: mixed lymphocyte culture 
(MLC); plaque-forming cell (PFC) assay; immunoglobulin quantitation, 
usually assessed by enzyme-linked immunosorbcnt assay (ELISA); mitogen 
assays; and either cell-mediated cytolytic (CMC) or natural killer-cell (NK) 
assay. 
The MLC is an assay in which lymphocytes from the experimental animals 
are co-cu ltured with an allogeneic cell line. Differences noted in the 
stimulation indeces between the cultures from xenobiotic-exposed an imals 
and those from non-exposed animals following pulsing with tritiated-
thymidine ([3H]-TdR) arc indicative of altered competency of cell-mediated 
immunity (CMI). A PFC assay eva luates the animals' ability to provide 
antibody-mediated immunity (AMI). Experimental animals are challenged 
with sheep red blood cells (SRBCs) ip 4 days prior to sacrifice, and their 
splenic lymphocytes are thereafter cultured with SRBCs and guinea pig 
complement. The ability of the cells to produce immunoglobulin M (lgM) is 
measured by observing zones of hemolysis surrounding individual PFCs. The 
total number of PFCs are counted in a given volume of culture solution, and 
the results are presented as both PFCs/!06 splenic cells and PFCs/spleen (both 
values are usually presented in case of variation in splenic cellulari ty caused 
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by xe nobiotic exposure). Further assess ment of AMI is performed by 
quantitating circulating plasma lgM levels by ELISA. 
Mitogen assays are performed to assess th e proliferative capabilities of 
both B and T lymphocytes followin g incubation with polyclonal ac tivators 
such as lipopolysaccharide (LPS), a B-ccll mitogen; concanavalin A (Con A) 
and phytohemagglutinin (PHA) , T-cell mitogens; and pokeweed mitogen 
(PWM), which st imulates both lymphocy te populations. The prolife rative 
capabilities of the cells is measured following the uptake of [3 H]-TdR. As 
pointed out by Luster et al. (1988), mitogen assays may not always correlate 
with the assays described above and are not necessarily indicative of alte red 
CM! or AMI. Non-specific immune responsiveness is measured by e ither CMC 
or NK assays, in which cells from the ex perim ental animals arc co-cultured 
with 51 Cr-labeled tumor cells. Tumor cell killing by experimental animal 
cells is quantitated by measuring radioisotope release into the c ulturing 
media. A CMC assay involves both cytotoxic T lymphocytes and NK cells, 
whereas the NK assay is performed following separation of these two cell 
types from one another. 
Tier ll immunotoxicologic testing is performed as a follow-up to positive 
tier assessment and includes the following assays: Quantitation of both B 
and T lymphocytes from the spleen; quantitation of immunoglobulin G levels; 
determination of cytolytic T -cell functionality; delayed hypersensitivity 
response; macrophage enumeration and a determination of their phagocytic 
abilities; and assessment of host resistance to antigenic challenge from 
syngeneic tumor cells, bacteria, viruses, or parasites (Luster et al., 1988). The 
latter series of assays, i . e., assessment o f host resistance to various antigenic 
challenge models, are of particu lar importance. This is because they 
represent the determination of an indirect o r secondary effect of toxic 
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xenobiotic exposure, the increased potentia l of incurring infectious or 
opportunistic disease following the direct or primary effect of the chemical 
in question. The direct effec t in this case involves a suppression of the 
immunocompetency of the exposed person or animal. 
Immunotoxicologic assessment is not currently required as part of the risk 
assessment process for environment al o r occ upational expos ures to 
chemicals. There are some researchers, however, who feel that the time is 
soon coming when suc h screening or assessment procedures will be 
legislatively required by various governmental regulatory agenc ies (Ex on e t 
a/. , 1986). The applicability and significance of positive tier-! results, 
demonstrating an immunotoxicologic chemical effect, are sti ll points of 
dispute in some circles (Loose, 1984, 1986, 1988). In fact, Luster et a/. (1988, p. 
4) readily admit that Tier I [testing) provides little information on the 
specificity of immune defect or its relevance to the host." They go on to say, 
however, that such testing " . . can readily discern an immune alteration 
resulting from chemical exposure." 
IMMUNGrOXJCOLCXJIC EFFECI'S OF N20 EXPOSURE 
Beyond the studies discussed above, which demonstrate that NzO adversely 
affects the hemopoietic system and may therefore have an impact upon the 
immune system, there are other studies which more directly describe NzO's 
effect upon various immunological parameters. Linnell et a/. (1978) and 
Quadros et al. (1979) have shown that NzO depresses the conversion of 
cyanocobalamin (CnCbl, the normal dietary form of vitamin B 1z) into MeCbl 
in human lymphocytes in vitro while having no apparent effect on the 
conversion of CnCbl to AdoCbl. However, Bruce (1976) showed that in vitro 
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exposure to 70% N 2 0 for between and 72 hr failed to inhibit the 
prolife ra tion of lymphocytes treated with phy to hemaggl utinin (P HA), as did 
Cullen and van Belle (I 975) wit h ce ll s fro m patients with minor or no 
surgery. although they did observe suppressed blastogenesis in the cells of 
patients who underwent what they termed stre ss -induced surgerie s. 
Cobalamin ox idation by unreponed amounts of N2 0 following 0.5 hr and 4 
hr in vitro exposures has resulted in decreased purine nucl eotide and Met 
syntheses in human lymphob lasts (Boss, 1985). Rats exposed to 20% and 40% 
N 2 0 were lymphocytopenic afte r 21 days, although there were no 
ab norm al itie s obse rv ed upon hi stologic examina t ion of the spleen. 
submaxillary lymph nodes, and intestinal tract (K ripke et al. , 1977). The 
greatest effect, however, occurred among the myeloid ce ll s, whi ch decreased 
both in total cell number and in mature forms (Kripke et al., 1977). 
Nitrous oxide exposure has been related to effects upon both leuko cytic 
chemotaxis and phagocytosis, although there is some controversy as to 
whether the effects are the direct result of exposure to the gas or are due to 
some surg ica lly induc ed stress mechani sm(s) invo lving e ith er biogenic 
amines or hormones or bo th. The chemotactic s tudies have been 
contradictory . Nunn and O'Morain (1982) ex posed human neutrophils for 15 
min to 80 % N20 in vitro, after which cell cu ltures displayed decreased 
mobility. Another in vitro s tudy involving both neutrophils and monocytes 
and 70% N2 0 for 30 min produced simi lar results (Moudgil et al., 1984). On the 
other hand , Hi ll et a/. (1978 ), in an in vivo study, ex posed 7 human vo lunteers 
to 60% N20 for I hr. Total and differential leukocyte counts were normal , but 
neutrophil chemotaxi s was increased rather than dec reased as in the in vitro 
studies. These re searchers suggested that the in vivo response to N2 0 may 
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have been due to the gas somehow altering circulating blood catecholamine 
leve ls. Finally , Welch and Zaccari (1982) demonstrated no abnormal 
chemotaxis by neutrophils, as measured by luminal dependent 
chemiluminescence, following exposure to 80% N20 in vitro. 
Only one study on phagocytosis has been found in the literature in 
conjunction with N20 administration. ln this study (Cullen, 1974), 80% N2 0 
ex posure of human leukocytes in vitro for 15 min resulted in a statistically 
non-significant decrease in the ability of the phagocytes to eng ulf latex 
panicles or to demonstrate nitroblue tetrazolium reduction. (NBT reduction 
involves a spectrophotometri ca lly observable co lor chan ge, which is 
indicative of active phagocytic processes and the cell's ability to kill ingested 
bacteria (Green, 1970)). 
Another area of interest is the influence N20 exposure may have upon 
immune system cells in their performance of cy totoxic functions. especially 
in relation to immunologic cancer surveillance (Kimball, 1986). Cullen et al. 
(1976) described the in vitro exposure of mouse peritoneal exudate cells to 
80% N2 0 for 4 hr. These cells were placed in culture with allogeneic tumor 
cells. and a 12% reduction in cytotoxicity was observed. Griffith and Kamath 
(1986) collected who le blood samples from female patients with eit her benign 
or malignant breast carcinomas. They then exposed these cells to 66% N20 
and 34% 02 for 5 min in vitro, following which the cells were co-cultured 
with K562 leukemia cells in a whole blood. natural cytotoxicity assay (Rees 
and Platts, 1983). Control assays were run following whole blood exposures to 
air only. No differences were noted between the cytotoxic abilities of the 
cells exposed to N20 and those exposed to air only from either the benign- or 
the malignant-tumor patients. 
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Vose and Moudgil (1975) collected and isolated peripheral blood leukocytes 
from 26 women with mammary carcinomas prior to and after the patients 
underwent their individual surgeries. The cy totoxic abilities of the cells 
taken from the patients following in vivo adm ini st ration of NzO (along with 
several other anesthetic drugs) was determined after culturing the isolated 
leukocytes in vitro with tumor cells taken from other mammary carcinoma 
patients . The results indicate that there was a decrease in the cytotoxic 
abilities of the leukocyte preparations postoperatively, compared to 
preoperative observations. Kumar and Taylor (1974) demonstrated 
transient decrease in the in vitro cytotoxicity of lymphocytes from surgical 
patients exposed to NzO in combination with most of the same anesthet ic 
drugs as above. Whether the decreased cytotoxicities were due to N20 
exposures or to the presence of the other drugs is unknown, and the 
possibility of surgically induced stress could not be ruled out (see also Pollock 
et a/ ., 1987). 
EFFECf OF N20 UPON BIOGENIC AMINES 
A brief discussion of the effect of N20 upon biogenic amines (BA) is 
necessary to facilitate the discussion of the interactions between the 
immune, nervous, and endocrine systems. Few stud ies have been performed 
that assess the effects of NzO ex posure upon BA concentrations in either the 
blood, the CNS, or the peripheral nervous system . Those studies that have 
been conducted have involved exposures to high doses of the gas. 
Additionally, NzO is generally administered in combination with other drugs, 
often at the time the person or animal undergoes surgery. These two factors 
may complicate the assessment of NzO effects. 
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Eisele (1985) reviewed a number of studies and case reports of the 
cardiovascular effects of N20 exposure and concluded that the results can be 
variable depending upon the combination of drugs and gases used with N20. 
In a study on plasma BA levels during surgical procedures, Halter et a/ . (1977) 
determined that surgical stress, and not anesthetic exposure, plays a more 
important role in observed neurochemical increase. In one particular study, 
in which the researchers attempted to control these factors (Eisele and Smith, 
1972), human volunteers were exposed to 40% N20 for 30 to 45 min per day for 
3 to 4 weeks. The volunteers' urinary epinephrine (E) and norepinephrine 
(NE) levels increased sl ightly, their plasma E levels were va riable , and in all 
cases their plasma NE concentrations rose sl ightly . 
changes were statistically significant. 
However, none of these 
Several researchers have described physiologic responses to N20 that are 
indicative of biogenic amine fluctuations, but the results are not consistent 
(Eisele, 1985; Rorie et a/. , 1986). While the evidence is still hypothetical that 
N 20 and morphine may produce similar biochemical consequences, studies 
have been conducted that relate the analgesic mechanism of N20 to that of 
morphine with its concomitant impact upon BA metabolism. For instance, 
Hynes and Berkowitz (1979, 1981, 1983) have shown that N20 and morphine 
both appear to induce concentration- and dose-dependent mouse locomotor 
stimulation, that this stimulation can be inhibited by ce rtain narcotic 
antagonists such as naloxone (although moreso in the case of morphine), and 
that both the gas and the drug have similar effects upon the same strains of 
mice. Morphine administration has been shown to be associated with the 
release of brain biogenic amines when stimulating mouse locomotor activity 
(Rethy et a/., 1971; Villarreal et a/. , 1973). In connection with the 
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morphine/N20 link discussed above, one might anticipate a simi lar result for 
N 20 administration (Hynes and Berkowitz, 1983), but no studies were found on 
this point. 
RELATIONSHIPS OF THE IMMUNE, ENDOCRINE, 
AND NERVOUS SYSTEMS 
It was formerly thought that regulation of the immune system beyond 
genetic controls (the major histocompatibility complex, for example) is 
completely au tonomou s (Locke and Colligan, 1986). Evidence has been 
presented in the last few years, however, which strongl y indicates that the 
immune and nervous systems act in concen. even to the point of sharing 
some reciprocal regulatory mechanisms in conjunction with the endocrine 
system (Besedovsky et al., !983). Studies have been performed that are 
indicative of the following dynamic interactions among the three systems: I) 
there is adrenergic innervation of lymphoid organs such as the spleen, 
thym us , lymph nodes, bone marrow, and gut-associated lymphoid tissue 
(Felten et al., 1985; Reilly et al., 1976, 1979); 2) there are adrenergic and 
neurohormone receptor sites located on some lymphocytes (Hadden et al., 
1970; Singh et al .. 1979); 3) alterations of brain biogenic amine levels may 
have either an enhancing or a suppressive effect upon lymphocyte 
fu nctions (Besedovsky et al., 1981; del Rey et al., 1981; Sanders and Munson, 
1985); and 4) immunocytes produce a number of chemical substances that can 
alter biochemical pathways within the CNS (Bescdovsky et al., 1983, 1985; 
Blalock, 1984). 
Others have described some of the interactions in further detail, in 
Jarticu lar the relationships between the endocrine and immune systems and 
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between the endocrine and nervous systems . For instance, Claman (1972) 
discussed the effects of adrenal glucocorticosteroids with both humoral and 
cell-mediated immunities, concluding that these hormones do indeed interact 
with lymphoid cells, although the cells' responses are both varied and species-
dependent. In an editorial, Tala! and Ahmed (1987) also briefly described 
these interrelationships and sta ted that , in addition to adrenal steroid 
hormones, other hormones , such as pituitary, growth, adrenocorticotropin 
(ACTH), and sex hormones, also regulate the immune system at least to some 
extent. 
Further evidence of immunoendocrine communication has recently been 
presented by Besedovsky et at. (1986), whose work suggests that an 
immunoregulatory feedback mechanism e xists between the T-cell 
lymphokine interleukin-1 and the endocrine hormones ACTH and 
gl ucocorticosteroids. Finally , McEwen (1987) reviewed the literature 
regarding the interactions between the endocrine and the nervous systems 
in relation to their modulatory effects on mood and behavior. He concluded 
that glucocorticosteroids: 1) raise serotonin (5-HT) and norepinephrine (NE) 
and possibly dopamine (DA) levels in the adrenal medulla and brainstem, 2) 
maintain phenylethanolamine N-methyl transferase (PNMT) activity in the 
adrenal medulla and brainstem and DA beta hydroxylase activity in the 
hypothalamus, and 3) increase tyrosine hydroxylase (TyrH) activity in the 
autonomic nervous system on short-term basis; but after several days 
decrease NE and 5-HT effects on the cerebral cortex and hippocampus. 
OCCUPATIONAL EXPOSURES TO N20 
It can be readily appreciated that NzO exposure has the potential to 
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produce, either directly or indirectly, varied effects within the body. These 
effects include bone marrow depression with concomitant decreases in 
leukocyte (myeloid and lymphoid) numbers; altered immune responses to 
exogenous or endogenous insult due to decreased lg production, cell 
chemotaxis, or cytotoxicity; and either positive or negative fluctuations in BA 
levels that may evolve from and result in a number of outcomes. As 
mentioned previously, there is no current United States ' health standard 
which defines a "safe" level for occupational N20 exposure . Nevertheless, 
NIOSH (Archer et al ., 1977) has recommended that N 2 0 exposures for health 
professionals be maintained at or below 25 ppm time-weighted average 
(TWA). The TWA is the average concentration to which most people may be 
exposed for up to 8 hr per day for 40 hr per week without any adverse effects. 
A TLV-TW A of 50 ppm has recently been recommended by the ACGIH 
(Anonymous, 1987). Several European countries have established legal 
standards for N2 0 exposures (5 ppm in Yugoslavia and I 00 ppm in Denmark, 
Norway, and Sweden) (Venables et al., 1983). 
Whether these health standards (both NIOSH's and the Europeans') arc too 
stringent remains a point of dispute. The NIOSH recommended standard, for 
instance, is based primarily upon studies by Bruce and Bach (1975, 1976) and 
Bruce et al. (1974), which purportedly demonstrate human behavioral effects 
following several hr exposures to 50 ppm of N2 0 rather than 25 ppm. 
However, studies by Allison er al. (1979), Smith and Shirley (1977 , 1978), and 
Venables er al. (1983) have failed to reproduce the results of Bruce and Bach 
(1975, 1976) and Bruce er al. (1974), even with N20 concentrations as high as 
500 ppm. Based upon teratogenic studies, Vieira er al. (1980) suggested that a 
standard of 30 ppm is too low, but they made no recommendations of their 
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own. Several studies have reported N2 0 concentrations in various 
occupational se ttings to be between 10 ppm and 3000 ppm in hospital 
operatories (Davenport et a/ ., 1980; Sonander et a/., 1985}, 78 ppm and 4600 
ppm TWA in dental operatorics with peak values as high as 24,000 ppm 
(Hanni fan et a/., 1978; Sweeney et a/., 1985}, and approximately 25 ppm TWA 
in veterinary operatories (Johnson et a/., 1987). 
As has been pointed out, most of the studies performed to date have 
assessed the toxic potential of N20 during acute, high-level exposures. It is 
felt that further study of occupational exposures that are representative of 
subchronic or chronic time periods is needed. This study was performed to 
assess some of the effects di scussed above at leve ls that more realistically 




One-hundred forty-four male CD-I mice (Charles River, Wilmington, MA) 
were numbered and randomly ass igned to 24 groups. One-half of the animals 
were exposed to either NzO or contro l air for a 2-week period (subacute study) 
and the other half for a 13-wcek period (subchronic study). When dosing 
was initiated, the mice were 4 to 8 weeks old and weighed between 26 and 38 g. 
Food and water consump tion was measured weekly per group, and each 
animal was weighed initially an d at the end of each week throu ghout the 
ex perim ent. The day following the second week of exposure for th e subacute 
study and the thirteenth week fo r the subchronic study, the mice we re 
sac rificed by decapitation and sp leens , li vers, kidneys, thymuses , and adrenal 
g land s we re remo ved and we ighed . 
removed. 
Blood and bone marrow we re also 
ANIMAL ACCLIMATION 
One week prior to their being exposed to Nz 0, the mice were acc limated to a 
daily routine of a 12-hr light period. Ambi en t room temperature was 
maintained at 75°F±5°F with a relative humidity of between 34% and 62%. 
Each day during the acclimation period , excluding the weekend, the animals 
were placed in 750-1, whole-body, dynamic ai r-flow inhalatio n chambers 
(Wahmann Manufacturing Co ., Timonium, MD) for 6 hr an d ex posed to 
approximately 10 chamber air changes per hr (ACH) of filtered room air. 
Chamber environmental conditions we re the same as those in the ambient 
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room environment. The mice were housed by group outside of the chambers 
du ring non-exposure periods and were maintained on commercial lab chow 
and water ad libitum. 
ANIMAL EXPOSURES TO N20 
Following the acc limation period, NzO exposures were initiated (the N2 0 
used in these studies was > 99% pure and was obtained from Ogden Welders 
Supply, Logan, UT). After placing the mice in the inhalation chambers, N20 
was introduced through nowmeters (Cole-Parmer Inc., Chicago, JL) into 
three of the chambers such that concentrations of 50.6 ppm ± 0.3 ppm NzO, 
502 ppm ± 1.4 ppm N20, and 4990 ppm ± 19 ppm NzO were achieved (Appendix 
A) . The fourth chamber received filte red room air only and housed the mice 
used as non-exposed controls. A schematic diagram of the exposure set-up is 
provided as figure III-I. As during the acclimation period, 10 ACH were 
maintained in each chamber, and environmental and all other conditions 
(temperature, humidity, food, time, etc.) we re controlled as previously 
described. The chambers we re maintained under a sl ightly negative 
pressure , and no Nz 0 was detected in the room air. Nitrous oxide 
concentrations we re measured using a MIRAN infrared gas ana lyzer 
(Foxboro Company, Foxboro, MA). It was calibrated prior to use by injecting a 
known volume of Nz 0 into the machine and noting the absorbance reading. 
Appendix B shows the ca libration cu rve obtained for the infrared analyzer. 
Prior to initiating animal exposure to Nz 0, sampling was performed to 
determine gas concentrations at different points throughout the chambers , 
especially at the level whe re the animal cages were to be placed during the 
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FIG. III-I. Schematic diagram of the inhalation chamber set-up used to 
administer nitrous oxide to the CD-I mice. 
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dosing regimen. There was an even distribution of NzO throughout each 
chamber, with < 4% variation from sample point to sample point. Even so, the 
animals were randomly placed in different locations within the chambers on 
a daily basis to control for the possibility of any variances in air flows and 
N zO concentrations that might occur. 
Immediately after the mice were placed in the chambers, N20 and mixing 
air were introduced by opening regulating valves to pre-determined settings. 
The time needed to achieve 99% of the maximum test concentration in each 
chamber was determined to be 15 min, afte r which time the 6 hr exposure 
period was observed. At the end of the exposure period, Nz 0 flow into the 
chambers was cu t off, and the chambers were allowed to exhaust any 
remaining Nz 0 for 15 to 20 min, after which the mice were removed from the 
chambers until the next day's exposure was initiated. All of the N20 
introduced to the chambers was exhausted through outlets on the roof of the 
animal test facility. Nitrous oxide concentrations in the inhalation chambers 
were routinely measured every 2 hr throughout the day, beginning 
immediately after achievement of the 99% concentration. 
IMMUNOLOGIC EXPERIMENTS 
The methods used were similar to those described by Hsieh et a/. (1988) and 
Srischuart et a/. (1987), with minor modifications. Spleens were removed 
aseptically and maintained in ice-cold, low-endotoxin RPM! 1640 media 
(Hyclone Laboratories, Inc., Logan, UT) supplemented 5% with fetal bovine 
serum (FBS) (Hyclone Laboratories, Inc., Logan, UT), 100 units of penicillin 
and 100 Jlg of streptomycin (Fisher Scientific Co., Pittsburg, PA) per ml of 
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media. The spleens were mashed in a model STOM 80 Stomacher® Lab Blender 
(Tekmar ® Company, Cincinnati , OH), producin g mononuclear splenic ce ll 
suspensions. These were transferred into 15-ml sterile conical centrifuge 
tubes, and the non-cellular debris was allowed to settle in the tubes for 10 
min, after which the contents were decanted into new sterile tubes. Cell 
numbers were determined by counting with a model D-2 Automatic Blood Cell 
Counter (Coulter Electronics , Inc ., Hialeah , FL). The cell suspension volumes 
were adjusted to between I to 2 X 107 cells/ml of media. The following assays 
were performed with the splenic cell cultures. 
Mitogen Assays 
Fifty .ul of splenic cells (approximately 0 .5 to I X !06 cell s/well) were 
cultured in triplicate in 96-well , Oat-bottomed microtissue culture plates 
{Becton Dickinson & Company, Oxnard, CA) either with or without 50 .ul of 
media containing concanavalin A (Con A) (Difco Laboratories, Inc., Detroit, 
MI) , lipopolysaccharide (LPS) from E. coli (Sigma Chemical Company, St. 
Louis, MO), purified phytohemagglutinin (PHA) (Wellcome Reagents Division, 
Greensboro, NC), or pokeweed mitogen (PWM) (Sigma Chemical Company, St. 
Louis, MO). The optimal concentration for splenic cell g rowth was 
determined by titration to be 0.39 .ug/ml for Con A, 50 .ug!ml for LPS, 1.56 
.ug!ml (subacute study) and 3.13 .ug/ml (subchronic study) for PHA, and 12.5 
.ug/ml for PWM. These concentrations were used in the assays. Control wells 
(those without mitogen) received 50 .ul of supplemented RPM!. 
An additional 50 .ILl of supplemented RPM! was added to each well, after 
which the cultures were incubated for 42 hr at 37°C in humidified air with 
4% COz. Each culture was then pulsed with 0.5 .uCi ( 18.5 kilobequerels (kBq)) 
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of tritiated -thymidine ([3 H]-TdR) (s peci fic ac tivity 2 Ci/mmol (74 
gigabequerels (gBq)/m mol) (New England Nuclear. Bos ton , MA) in 50 pi of 
media. Incubation was cont inued for 6 hr, after wh ich the sp lenic cells were 
harvested with a Brandel model M-12 ce ll harveste r (Biomedical Research 
and Development Laboratories Inc., Gaithersberg, MD) onto 2.1 em glass 
microfiber filters (Whatman Ltd., Maidenstone , Eng.). The filters were then 
placed into 7 ml scintillation counting vials and dried overnight in the dark 
at room temperature. The following day 5 ml of ScintiVerse"' liquid 
scintillation cocktail (Fisher Scientific Co., Pittsburg, PA) was added to each 
vial, after which the amount of tritium activity was determined in each well 
in Packard model Tri-Carb 2660 liquid sc intillation counter (Packa rd 
Instrument Company, Inc., Downers Grove , IL). 
Mixed Lymphocyte Culture 
A one-way, mixed lymphocyte culture assay (MLC) was performed using 
mitomycin C-treated stimulator YAC-1 mouse splenic cells (Moloney virus 
induced T-lymphoma cells from A/Sn [H-2] mice, American Tissue Culture 
Collection (ATCC), Rockville , MD). Two sets of sp lenic responder ce lls were 
utilized , one treated wi th (control) and one without (e xperimental) 
mitomycin C. For the control cultures, 50 Jll (0.25 to 0.5 X 106 cells/well) of 
treated responder cells were co-cultured in triplicate in 96-well, flat-
bottomed microtissue culture plates with 50 pi (0.125 to 0.25 X !06 cells/well) 
of non-mitomycin C-treated CD-I mouse splenic ce lls. These cultures were 
then pulsed with 0.5 JLCi (18.5 kBq) of [3H]-TdR (6 hr pulsing for the subacute 
study, 24 hr for the subchronic study, both performed during the latter 
portion of the culture incubation period) in 50 pi of supplemented RPM! 
media. Finally, 5 X 10 -5 M mercaptoethanol was added to each well. The 
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procedure for the ex perimental cultures was the same as for the control 
cultures , except that 25 111 of the YAC-1 splenic ce lls (0. 125 to 0.25 X 106 cells) 
was mixed with 100 111 of the untreated responder cells (0.25 to 0.5 X 106 cells) 
in each well. The cul tures were incubated for 72 hr at 37°C in humidified air 
with 4% C02. Cell-harvesting and liquid-sc intillation procedu res were the 
same as described for the mitogen assays. 
/nter/eukin-2 Assay 
An interleukin-2 (IL-2)-dependent mouse cell line (HT-2) (from BALB/c 
mice) (Watson, 1979) was cultured in triplicate with test supernatants of 
varying concentrations produced from the T lymphocytes of the N2 0 exposed 
CD-I mice . The HT-2 cell line was maintained in medium consisting of 60% 
(by volume) RPM! supplemented 10% with FBS, 50 units of penicillin/ml, 50 
11g of streptom ycin/ml, 40% (by volume) of RPM! containing 5 units of rat 
spleen cell IL-2 (Sigma Chemical Company, St. Louis, MO) per ml of media, and 
5 X 10-5 M mercaptoethanol. Prior to being mixed with the CD-I test 
supernatant, the HT-2 cells were washed and resuspended in fresh RPMI-FBS-
antibiotic medium at a concentration of I X JQS ce lls/mi. Fifty 111 of the HT-2 
cell culture (5 X !03 ce lls) was then added to each well of 96-well, flat-
bottomed microtissue culture plates along with varying concentrations of test 
supernatants (undiluted, 50%, 25%, and 12.5%). The cultures were incubated 
for 24 hr at 37°C in humidified air with 4% C02 . One-half of I tLCi (37 kBq) of 
[3H]-TdR in 50 111 of supplemented RPM! was then added to each well and 
incubation was continued for ano ther 4 hr, after which the cells were 
harvested and counted by liquid scintillation as previously described. 
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Cell-Mediated Cytolysis 
The cyto lyt ic activity of cytotoxic T lymphocytes and nonspecific 
accessory ce lls , such as natural killer (NK) ce ll s, was measured as described 
by Grabstein (1980), with modifications (Hsieh et al ., 1988). YAC-1 cells were 
utilized as the an ti genic target (stimulator). Prior to their use in the assay, 
the Y AC-t ce ll s were checked both to ensure that they were in a log-growth 
phase and at least 90% viable. They we re then suspended in RPM! media 
suJplemented 10% with FBS and 50 JLg/ml streptomycin and 50 units/ml 
pe1icillin at a concentration of l X 106 cells/mi. For every ml of cell 
su;pension 50 JLg of mitomycin C was added , after which the ce lls were 
incubated at 37°C in humidified air wi th 4% C02. 
At the end of I hr, I X I 07 ce lls were transferred to a 50-ml conical 
ceurifuge tube and 250 JLCi (9.25 MBq) of 51Cr (spec ific activity 200-900 Ci/g 
(7.4-33.3 teraBq/g) New England Nuclear, Boston, MA), given as sodium 
chcomate, was added. This mixture was incubated for I hr with gentle 
ag.tation. Subsequently, the cells were pelleted by centrifugation fo r 10 min 
a t 200 X g and 4°C. The supe rnatant was then decanted, and the cells were 
remspended by the addition of approximately 5 ml of FBS. The ce lls were 
c u lured fo r 30 min, re-centrifuged, then re-suspended in supplemented 
RFMI at a concentration of I X 105 cells/mi. 
Varied concentrations (I X 107, 5 X 106, and 2.5 X 106 cells/ml) of the CD-1 
mcuse splenocytes (effector o r responder ce ll s) were co-cultured in triplicate 
in 100 JLl volumes with 100 JLl of the YAC-1 cell cultures in 96-well, flat-
bo tomed microtissue culture plates for 4 hr at 37°C in humidified ai r with 4% 
co 2· Control cultures measuring either the spontaneous or the maximal 
rebase of 51 Cr were run concurrently with the experimental cultures. The 
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control cultures had I 00 Jll of cell growth media or 1 DO Jl] of 1% (w/v) 
saponin (NP40) added, respectively, rat her than the CD-I sp lenoc yte 
suspension . Also, lO.ui (\50 units) of mo use fib robl ast interferon (Sigma 
Chemical Company, St. Louis, MO) was added to all except the control well s. At 
the end of the incubation period, the cultures were centrifuged at 250 X g for 
10 min at 4°C. Being careful not to disturb the cell pellet, I DO Jll of the 
supernatant was removed from each well , placed into scintill ation vials, an d 
measured for radioactivity wi th a model 578 gamma sc intill ation counter 
(Packard Instrument Company, Inc ., Downers Grove, IL). 
Plaque-Forming Cell Assay 
A plaque-forming cell (PFC) assay was performed to determine the ab ilit y 
of splenic lymphocy tes from the test mice to respond to an antigenic 
challenge by sheep red blood cells (SRBCs) following N2 0 exposures. The 
methods employed were basicall y as described by Jerne and Nordin (1963). 
Ninety-six hr prior to their being sac rificed, the mice were given , ip, 0.25 ml 
of a solution consisting of 20 % (by vo lume) SRBCs in sterile physiologic 
saline solution. Following the injections, the animals continued to be exposed 
to N2 0 as before until they were sacrificed. Spleens were aseptically removed 
and weighed, and a monocellular splenic cell culture was made as previously 
described . In order, 450 Jl] of freshly prepared SRBC solution (10% SRBCs, by 
volume), 100 Jll of guinea pig complement (Gibco Laboratories, Grand Island , 
NY), and 450 Jll of the splenic cell suspension ( \ X 107 cells/ml) were added to 
sterile 12 X 75 mm test tubes and mixed thorou ghly. Aliquots of the mixtures 
(I per test animal) were then added to the preweighed microchambcrs 
described previously (Cunningham and Szenberg, 1968). The chambers were 
then sealed wi th a paraffin/Vase line mixture. The chamber cultures were 
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incubated for 1 hr at 37°C, after which the number of plaques per chamber 
wue counted. 
Immuno globulin Quantitation 
An antibody (Ab) titer for immunoglobulin M (IgM) was conducted by an 
indirect , enzyme-linked immunosorbent assay (ELISA) (Voller and Bidwell , 
1986). The blood samples used in the assay were obtained from the same mice 
used in the PFC assay . Ninety-six-well , flat-bo!lomed, polystyrene microtissue 
culture plates (Dynatech Laboratories , Inc., Alexandria , VA) were coated with 
!OJ J.Ll of SRBC ghosts (prepared as described by Hanahan and Ekholm (1974)) 
diuted to protei n co ncentration of 3.6 ILg/ml in p H 9. 6 ca rbonate -
bicarbonate buffer. After the plate wells were filled with the SRBC ghost 
so.ution, the plates were covered with parafilm and stored at 4°C for 24 hr. 
Fdlowing the storage period, the plate wells were washed three times with 
phosphate-buffered saline containing 0.05 % Tween 20 (PBS-Tween). 
Serum samples from the test animals were collected and diluted 1:50, I : 100, 
an1 1:200 in PBS-Tween, after which 100 ILl of each serum sample dilution was 
adied in triplicate to the ghost-coated wells. The samples were incubated for 
I hr at room temperature . The wells were then re-washed three times with 
PES-Tween and 100 ILl of peroxidase-conjugated goat anti-mouse lgM, diluted 
I ::000, was added to each well for I hr. The wells were washed as before, then 
101 J.Ll of substrate (0.4 mg/ml a-phenylenediamine in pH 5 phosphate citrate 
bu'fer and 0.4 J.Ll/ml of 30% Hz 0 z) was added to each well. After 20 min, the 
re~ction was stopped by adding 50 ILl of I N HCl to each well. The optical 
detsity was determined for each well on a model EL309 microplate autoreader 
(Bo-Tek Instruments, Inc., Burlington, VT) using an absorbance of 490 nm. 
Nm-SRBC-sensitized mouse serum served as a negative control. 
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BLOOD SYSTEM ASSESSMENTS 
Ratline Hematology 
Total red and wh ite blood cell counts we re pe rformed using a model D-2 
Attomatic Blood Cell Counter (Coulter Electronics. Inc.. Hialeah, FL). 
Drferential leukocyte counts were conducted following standard white blood 
ee l staining procedures. Additionally , hematocrit determinations we re made 
fo · each animal using microhematocrit eq uipment , and he moglobin 
cotcentrations we re defined using a model Hemo-W® hemoglobinometer 
(Cmlter Electronics, Inc., Hialeah. FL). 
Dwxyuridine Suppressio n Tes t 
A deoxyuridine suppression test was performed as described by Town er a/. 
(I •86), with slight modifications. Cell samples were obtained fro m the long 
botes of the hind limbs of the mice as described by Mishell and Shiigi (1980). 
Aler producing monocellular bone marrow suspensions. 100 ,ul (5 X !OS cells) 
of the cell cultures was added in two triplicate sets per animal to 96-well fiat-
botomed microtissue culture plates along with 10 ,ul of autologous serum. 
N()(t, either 20 ,ul of thymine- and thymidine-free 2'-deox yuridine (d UdR) 
(Sgma Chemical Company, St. Louis, MO) at a concentration of 0.1 ,umol/ml or 
20 ,ul of Hank's Balanced Salt Solution (HBSS) was added to each well. The well 
voumes were adjusted to 190 ,ul with the addition of HBSS, and the cultures 
we-e then incubated for I hr at 37°C in humidified air with 4% COz. 
At the conclusion of the incubation period, each well was pulsed with 5 ,uCi 
(1!5 MBq) of [3 H]-TdR (specific activity 2 Ci/mmol (74 MBq/mmol)) in 9.5 ,ul 
of HBSS. The cell cultures were then re-incubated for an additional hr. Cell 
ha;vesting and liquid scintillation procedures were as previously described 
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fo r the mitogen assays. 
ENDOCRINE HORMONE MEASUREMENTS 
Radioimmunoassay (RIA) procedures we re utilized to measure se rum levels 
of both adrenocorticotropic ho rmone (ACTH) and co rticosterone. To control 
for the va riability often seen in endocrine hormone se rum concentrations 
thrmghout the day, samples were obtained and assays run at the same time of 
day fo r all of the animals in both the subacu te and subchronic N20 -dosin g 
grOJps. Kits fo r the RIAs 
Laloratories. Inc ., Ca rson , CA. 
were 
and 
ob tained from 
we re used as 
Radioassay Sy stems 
directed with sli ght 
moiifications. Plasma samples we re obtained from each animal by co llecting 
blood from the carotid artery into chilled, NaEDTA-coated tubes at the time of 
aninal sacrifice. The cellul ar constituents of the samples were pelleted by 
cell rifugation at 200 X g for 10 min at 4°C, after which the plasma was 
carefully suctioned out of the tubes by pipet, placed into 1.5 ml tubes, and 
frmen at -20°C until the ho rmone anal yses were performed later during the 
week. 
Adlenoconicotropic Hormon e 
Just prior to their use, lyophilized reagents were reconstituted and mixed 
wit! kit-supplied water and allowed to sit at 4°C for 15 min, after which 0.1 ml 
of 1iluent water, varied standard ACTH concentrations, or plasma was pipetted 
intc duplicate kit vials and kept on ice throu ghout the procedure. Next, 0.1 ml 
of tnti-ACTH was added to all tubes except those with diluent water, followed 
by he addition of 0.1 ml of I25I-ACTH. Tube contents were mixed thoroughly 
and then incubated at 4°C for 16 hr. At the end of the incubation period, 0.5 
ml of precipitant solution was added to each tube and mixed in we ll. The 
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into a liquid-waste 
with a model 578 
container. Radioactivity in 
gamma sc intillation counter 
(P;ckard Instrument Company , Inc .. Downers Gro ve, IL). 
C (T ticosterone 
Plasma samples were obtained from the mice as described above for the 
ACTH assay but were diluted I :200 with the steroid diluent provided with the 
kit (10 Jll of plasma in 2 ml of diluent). All reagents were brought to room 
tenperature prior to use, then 0.1 mi of diluent buffer, varied standard 
co ·ti costerone co ncentration s, o r diluted plasma samples we re ad ded to 
du!Ii cate 10 X 75 mm polystyrene centrifuge tubes . Next, 0.2 ml of t25I-
conicosterone was added to each tube , followed by 0.2 ml of anti-
cot icosterone. The tube contents were mixed followed by incubation for 2 hr 
at room temperature . At the conclusion of the incubation period, 0.5 ml of 
pre:ipitant solution was added to each tube and mixed for 20 sec. The tubes' 
cortents were centrifuged for 15 min at 1000 X g, and the supernatants were 
thet decanted into a liquid-waste container. The radioactivity in each pellet 
wa; measured by a gamma counter as described above. 
STATISTICAL ANALYSES 
The data from each of the above experimental procedures were tested for 
honoscedasticity by Bartlett's method (Snedecor and Cochran. 1967). Data for 
whch homogeneity of variance could be assumed were tested for statistical 
sigtificance by one-way analysis of variance (ANOV A) using the F statistic. 
Int:rgroup comparisons were made by Student-Newman-Keuls ' procedure 
(Dcwdy and Wearden, 1983). Values :;; 0.05 were used to determine statistical 
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siglificance. Data for which heterogeneity of variance was assumed were 
tesed for s tatistical significance (p s 0.05) by the non-parametric Mann-




The results obtained from monitoring foo d and water consumption are 
unr:markable, insofar as the observation of any specific trends are 
con:emed. It should be noted , however, that the use of these items by the 
diff:rent animal groups fluctuated greatly throughout the s tudy period, and 
that the control animals in the 13 -week study appeared to consume more food 
and water on a weekly basis than did the animals exposed to N2 0. The results 
of these measurements are presented as Table lV-1 (food and water 
con:umption for the 2-week study animals) and Figures IV -1 and IV -2 (food 
and water consumption for the 13-week study animals) . 
SUBACUTE EXPERIMENTS 
Bod1 and Organ Weights 
By the end of the first week of exposure, mice from the 500-ppm dosing 
!eve demonstrated depressed body weight gains (p < 0.05), compared to both 
the control animals and those at the 5000-ppm level (Table IV-2). This trend 
was observed to continue through the second week as compared to the high-
doshg level (5000 ppm) animals only. Relative liver weights of animals 
exp<sed to 500 ppm were decreased (p < 0.05) compared to controls and 5000 
ppm animals (Table IV-3). 
Imnuno/ogic Assessments 
Both B- and T-splenic lymphocyte responsiveness to various mitogens 
wen significantly depressed (p < 0.02 for LPS and p < 0.01 for Con A, PHA, and 
TABLE IV-I 
FOOD (G) AND WATER (ML) CONSUMPTION BY CD-1 MICE DURI~G 
2-WEEK EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Food consumed Water utilized 
concentration I lml 
(ppm) Week 1 Week 2 Week 1 Week 2 
0 224.1 231 .6 493.2 559.3 
50 202.1 204.7 552.8 447.8 
500 220.8 231.1 480.2 480.6 
5000 215.7 224.6 552.3 527.2 
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PWN) at 5000 ppm, compared wi th 0 ppm mouse cells when measured as total 
[3H]TdR ce llular incorporation (T able IV-4). Interest ingly , however, Con A 
and PHA, immature and total T-cell mitogens. respectively, and LPS, a B-cell 
s timtlator, produc ed no ticeabl e bu t statist ica ll y no n-signifi cant de creased 
mito ;enic activity at 50 ppm compared wi th 0 ppm ce lls . The ac tivity 
obse ••ed in the median-dosing group was comparable to the activity noted in 
the :ells from animals not exposed to N2 0. Pokeweed mitogen (PWM) 
stimtlation dose-responsively decreased with increasing NzO exposure. 
As shown in Table IV-5, both the 500 ppm animals' cells (p < 0.05) and the 
5000 ppm ani mals' ce lls (p < 0.0 1) took up less [3 H)- TdR than did the 0 ppm 
an im .ls" cells, whether they were co-cu ltured with YAC-1 cells or not. T-
1ymplocyte interl cukin-2 (IL-2) production , shown in Table JV-6, was 
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F!G JV- 1. Food consumption (g) by CD-I mice during 13-week exposures to 
nitnus oxide. 
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FIG . IV-2. Water utilization (ml) by CD-I mice during 13-week exposures to 
ni trots ox ide . 
TABLE IV-2 








0 103.33±0.77 1 07. 75±1 .66 
50 1 01 .95±0.81 1 04.58±1.03 
500 1 00.93±0.61 b,c 103.75±0.61b 
5000 1 03 .53±0.66 1 07.25±1.41 
a - Data presented as the means±SE (n = 6) . Expressed as a 
percentage of the body weights (g) measured prior to exposure 
regimen initiation . 
b - Significantly different from 0 ppm at p < 0.05. 
c - Significantly different from 5000 ppm at p < 0.05. 
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TABLE IV-3 









Spleen Thymus Liver Kidneys 
0.34±0.02 0.1 0±0.01 5.81±0.11 1.65±0.06 
0.28±0.02 0.1 0±0.01 5.78±0.16 1.61±0.12 
0.35±0.05 0.10±0.01 5.35±0.06b 1.61±0.09 







a - Data presented as the means±SE (n = 6). Expressed as the organ weights (g)/1 00 
g body weight. 
b - Significantly different from both 0 ppm and 5000 ppm at p < 0.05. 
virtually unaltered following N2 0 exposures. No differences were noted in 
cell-mediated cytolytic capabilities (Table JV-7). 
Humoral responses, as measured by a plaque-forming cell (PFC) assay and 
by enzyme-linked immunosorbent assay (ELISA), quanti tating sera anti-SRBC 
antibody titers are presented in Table IV-8 and Figure IV-3, respectively. The 
number of PFCs observed at each exposure level was approximately equal 
whether calculated as PFCs/106 or PFCs/total spleen cells. Circulating 
antibody levels for SRBCs were si milar for all exposure groups with only one 





CD-I MOUSE SPLENIC LYMPHOCYTE PROLIFERATIVE RESPONSES TO MITOGENIC 
SUBSTANCES FOLLOWING 2-WEEK ANIMAL EXPOSURES TO NITROUS OXIDE 
Spleen Mitoaenic resoonsesb 
cellularity• No Mitogen Con A PHA LPS PWM 
0 1.12±0 .03 4.68 ±0 .35 94.81 ±25.64 79.26±15.14 78.32 ±21 .3 4 24.24±6.42 
50 1.19 ±0 .09 4.52 ±0.33 41.39± 7.48 32.48± 4.81 52.72 ±14.07 18.99±5. 58 
500 1 .22±0. 12 3.90 ±0.24 81.84 ±30.90 62.07±21.33 61.52 ±18 .45 12.21 ±3.72 
5000 1.02±0.04 4.23 ±0.24 13.98± 2.97d 14.67± 3.28d 16.74± 3.66d 6.55i 1.QQd 
a - Number of lymphocytes recovered/spleen X 1 a-s. 
b - dpm/ t as splenic lymphocytes X 1 Q-3, response evaluated by 3H incorporated after 6 hr pulsing. 
Data presented as the means±SE (n = 6 except 0 ppm where n = 5) . 
c · Significantly different from 0 ppm at p < 0.01 . 




TRITIATED-THYMIDINE UPTAKE BY CD-I MOUSE SPLENIC 
LYMPHOCYTES IN MIXED CULTURE WITH MITOMYCIN-C 
TREATED Y AC-1 CELLS FOLLOWI NG 2-WEEK 
ANIMAL EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Responders Responders/ 
concentration dpm/1 os cells stimulators 
(ppm) (X 10·3) dpm/1 os cells 
(X 10-3) 
0 6.6±1.6 8.7±2.0 
50 4.8±0.6 4.6±0.6 
500 3.2±0.3b 4.1±0.4b 
5000 2.0±Q.1C 2.1±0.2C 
a - Data presented as the means±SE (n : 6 except for o ppm where n = 5) . 
b -Significantly different from 0 ppm at p < 0.01. 
c -Significantly different from 0 ppm, 50 ppm, and 500 ppm at p < 0.01 . 
TABLE IV-6 
HT-2• CELL RESPONSE TO INTERLEUKIN-2 PRODUCED BY 
SPLENIC LYMPHOCYTES FROM CD-I MICE EXPOSED 
TO NITROUS OXIDE FOR 2 WEEKS 
Nirous oxide Slirnulatico iodi!;;~:sb,c 
co1centration IL.-2 CCDC!lDiraliCOd 
(ppm) 100 50 25 12.5 
0 16.0±1.2 13.8±1.2 10.6±0.4 9.4±0.7 
50 16.2±1.8 14.2±1.4 11 .9±2.3 9.9±0.9 
500 12.1±1.3 8.1±0.58 9.3±0.9 6.8±0.4 
5000 13.1±1.8 12.1±0.8 9.4±0.9 7.2±1.0 
a HT-2 cells are dependent upon the presence of IL-2 for proliferative 
re1ponse. 
b · Data presented as the means±SE (n = 6 except for 0 ppm where n = 5) . 
c · Ratio of dpm from 3H incorporation into HT-2 cells cultured 
in supernatant containing IL-2 from CD-1 mouse splenic lymphocytes 
cutured with Con A to dpm from 3H incorporation into HT-2 
eels cultured in supernatant containing IL-2 from CD-1 mouse splenic 
lynphocytes cultured without Con A. 
d % of original splenic lymphocyte supernatant containing IL-2. 
e · Significantly different from 50 ppm at p < 0.05. 
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TABLEIV-7 
CELL-MEDIATED CYTOLOYSIS OF Y AC-1 TARGET CELLS BY 
SPLENIC LYMPHOCYTES AND NON-SPECIFIC KILLER 
CELLS FROM CD-I MICE EXPOSED FOR 2 WEEKS 
TO NITROUS OXIDE 
Nitrous oxide Eer!;;flDI 51 Qr release•.b 
concentration 1QQ;1C 50:1c 25:1c 
(ppm} 
0 797±185 462±261 710±205 
50 478±237 101±125 _d 
500 924±125 821±136 529±107 
5000 563±143 -d 363±143 
a - Data presented as the means±SE (n = 6 except for 0 ppm where n = 5} . 
b - Expressed as: (dpm/1 06 target cells minus spontaneous dpm/1 Q6 target 
cells} X 10-2. 
c - Effector cell:target cell ratio . 
d - Not reported due to technical error. 
Note: Maximal 51 Cr release was measured as 3753 dpm/106 target cells and 
spontaneous as 945 dpm/1 Q6 target cells, both X 1 o-a . 
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TABLE IV-8 





























b - Number of lymphocytes recovered/spleen X 1 o-s_ 
c - Plaque forming cells. 
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1:50 1:100 1:200 
serum dilution 
FIG IV-3. Enzyme- linked immunosorbent assay quant itati on of anti-sheep 
red llood cell immunoglobulin M levels from the sera of CD-I mice ex posed to 
nitrOJs oxide for 2 weeks. Titers measured in absorbance units. Presented as 
the means±SE (n = 6). *50 ppm significantly different from 0 ppm at I :50 
diluton. p < 0.05. 
Hemuologic Parameters 
The results of the routine hematologic assessments are presented in Table 
IV -9 While statist ic al s ignificance was not observed. the tota l number of 
leukccytes in the high-dose group was between 13% to 17% less than 
that measured in any of the other three groups. 
There were no obvious trends noted in the cell ularity of the animals' bone 
marrows (Table IV-10) and, although there were no st ati stical differences 
seen among the various dosing groups in the deoxyu ridine supp re ssion test 
(dUd~ST), all three groups receiving N20 had dUdR suppression va lues 10% 
highrr than those seen in the control group (Figure IV-4). 
Enda:rine Hormones 
No intergroup differences were noted in ei1her the serum conicos terone 
or A:TH level (data not presented ). 
TABLE IV-9 
HEMATOLOGICAL PARAMETERS• FROM CD-1 MJCE FOLLOWING 2-












1 0.01±0.40 48.9±1.3 
10.44±0.14 47.6±0.5 
9.64±0.07 49.2±0.7 
10.25±0.23 49.1 ±1.2 







b - Includes monocytes, eosinophils, and basophils. 







Leukocvte differentials I% ) 
Lymphocytes Neutrophils Othersb 
70±4 24±4 6±1 
74±3 21±3 5:!.1 
67±6 26±5 7:!. 1C 




BONE MARROW CELL RESPONSES• OF CD-1 MICE FOLLOWING 
2-WEEK EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Bone marrow dUdR Normalizedd 
concentration cellularityb suppression dUdR suppression 
(ppm) value (%)c value (%)c 
0 6.42±0.38 87.4±2.9 1 00.0±3.3 
50 5.73±0.31 97.3±3.9 111.3±4.5 
500 5.75±0.81 97.3±5.2 11 0.4±5.9 
5000 6.40±0.21 96.5±7.7 111 .3±8.8 
a - Data presented as the means±SE (n = 6). 
b - Expressed as the total number of bone marrow cells collected 
from both femurs X 1 Q-7. 
c - Expressed as the amount of [3H]-TdR uptake after preincubation 
with deoxyuridine (dUdR) as a percentage of uptake without 
preincubation with dUdR. 
d - Normalized to 100% for 0 ppm values . 
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FIG. IV-4. Deoxyuridine suppression test performed on CD-I mouse bone 
marrow cells following 2-week animal exposures to nitrous oxide . Presented 
as the means±SE (n = 6). 
SUBCHRONIC EXPERIMENTS 
Body and Organ Weights 
While no statistically significant differences were observed between the 
dosing groups, Figure IV-5 shows that the body weights of the animals in all 
three groups receiving N20 appeared to be slightly less than those receiving 
no N20, especially during the second half of the exposure regimen. These 
same animals' relative liver weights (Table IV-I!) were substantially (p < 
0.01) reduced compared with control animal liver weights, as we re the 
adrenal weights in the animals from the 500-ppm dosing group (p < 0.05). 
Immunologic Assessments 
As seen with the subacute mice, the splenic lymphocytes from the 
subchronic animals dosed with 50 ppm of N20 manifested decreased [3 H]-TdR 
uptake after culturing with either Con A, LPS , or PHA (Table IV-12), but , as at 
2 weeks, the lower numbers observed were not statistically different from the 
values associated with the 0-ppm cells. However, there was increased 
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TABLE IV-II 
ORGAN WEIGHTS a OF CD-1 MJCE FOLLOWING 13-WEEK EXPOSURES 
TO NITROUS OXIDE 
Nitrous oxide Spleen Thymus Liver Kidneys Adrenals 
concentration (X 102) 
(ppm) 
0 0.31±0.02 0.04±0.01 5.78±0.14 1.79±0.09 1.00±0.05 
50 0.22±0.01 0.07±0.01 5.04±0.07b 1.58±0.06 0.86±0.06 
500 0.29±0.03 0.04±0.01 5.13±0.11 b 1.70±0.04 0.77±Q.Q9C 
5000 0.29±0.03 0.06±0.01 5.01±0.14b 1.58±0.07 1.ot±0.04 
a - Data presented as the means±SE (n = 6). Expressed as the organ weights (g)/1 00 
g body weight. 
b - Significantly different from 0 ppm at p < 0.01 . 
c - Significantly different from 0 ppm and 5000 ppm at p < 0.05. 
TABLE IY-I2 
CD-I MOUSE SPLENIC LYMPHOCYTE PROLIFERATIVE RESPONSES TO MITOGENIC 
SUBSTANCES FOLLOWING 13-WEEK ANIMAL EXPOSURES TO NITROUS OXIDE 





Con A PHA LPS 
0 1.70±0.14 11.52±1.22 184 .96±47.91 301.46 ±77 .22 177 .11±30.35 




500 1.18±0.06C 27 .21±4.56 331.29 ±78.49 415 .60 ±29 .67d 241.4 7±33 .07d 140. 99 ±37 .52 
5000 1 .64±0 .1 4 33.65±9.52 9 354.00±80.24 397 . 72 ±6 7 .26d 304 . 94±26 .36d 146. 5 1±4 3.31 
a - Number of lymphocytes recovered/spleen X 10·8 . 
b . dpm/1 os splenic lymphocytes X 1 0·3, response evaluated by JH incorporated after 6 hr pulsing. 
Data presented as the means±SE (n = 6). 
c - Significantly different from both 0 ppm and 5000 ppm at p < 0.05. 
d · Significantly different from 50 ppm at p < 0.01. 
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FIG. IV-5. Body weights of CD-1 mice during 13-week exposures to nitrous 
oxide. Presented as the means±SE (n = 6) and expressed as a percentage of the 
body weights measured prior to exposure regimen initiation . 
radioisotopic uptake at the two higher N2 0 concentrations, significantly so (p 
< 0.0 1) for PHA- and LPS-cultured cells compared to 50 ppm cells. Control (no 
mitogen) cell-culture [3H]-TdR uptake at 0 ppm and 50 ppm was similar, but 
there was significantly inc reased tracer uptake (p < 0.05) at 5000 ppm 
compared to both lower-exposure groups. There was also increased uptake of 
[3H]-TdR by 500 ppm cells, which approached levels of significance (0.05 < p < 
0. 10) compared to 0 ppm and 50 ppm cells. 
Unlike their 2-week counterpans (Table IV-5 ), in which decreased [3H]-
TdR uptake was noted at higher N 2 0 exposure levels, the CD-1 splenic 
lymphocytes in MLC following 13-week gas exposures manifested increased 
radioisotopic uptake (p < 0.05) compared with both 0-ppm and 50-ppm cells 
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(Table lV-13). 
The IL-2 assay, while performed under indentical conditions as those in the 
subacute study, resulted in no HT-2 cell response (data not presented) to Con A-
stimulated CD-I mouse lymphocyte supernatant versus non-stimulated cell 
supernatant. The cell-mediated cytolytic assay results (Table IV-14) 
mimicked those seen in the subacute study, with cell killing and subsequent 
51Cr release measured at levels too low (~ 4%) to detect any differences 
between N2 0 dosing groups. 
Relative thymus and adrenal gland weights of animals challenged ip with 
SRBCs were significantly decreased (p < 0.05) at 5000 ppm compared with the 
500-ppm and 50-ppm groups (Table IV-15) . The number of plaque-forming 
cells/1 06 splenic cells and per spleen was significantly less (p < 0.05) for 5000-
ppm animals compared with control animals (Table IV-16). Anti-SRBC serum 
antibody titers (Figure IV -6) were reduced after 5000-ppm exposures 
compared to both 0-ppm and 500-ppm animals. 
Hematologic Parameters 
Table IV-17 shows the routine hematologic data collected from the 13-week 
study. Red blood cell data show no effect relative to NzO dosing. White blood 
cells (wbc), however, appear to be greatly affected by animal exposures to 
the gas, as the total leukocytes per mm3 of blood in the Nz 0-dosed animals 
were significantly decreased (p < 0.01) compared to control animals . 
Bone marrow cellularity is slightly higher in those animals dosed with N20 
than in control animals (Table IV-18). Figure IV-7 shows that bone marrow 
cells, as measured by the deoxyuridine suppression test, were dose 
responsive with regards to Nz 0 exposure, significantly so at the two higher 
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TABLEIV-13 
TRITIATED-THYMIDINE UPTAKE BY CD-I MOUSE SPLENIC 
LYMPHOCYTES IN MIXED CULTURE WITH MITOMYCIN-C 
TREATED YAC-1 CELLS FOLLOWING 13-WEEK 
ANIMAL EXPOSURES TO NITROUS OXlDE 
Nitrous oxide Responders Responders/ 
concentration dpm/1 os cells stimulators 
(ppm) (X 10-3) dpm/1 os cells 
(X 10-3) 
0 16.7±3.9 25.4±3.4 
50 18.2±1.9 23.6±4.5 
500 25.0±3.0 43.1±5.5b 
5000 25.8±1 .2 41.0±3.5C 
a - Data presented as the means±SE (n = 6 except foro ppm where n = 5). 
b - Significantly different from both 0 ppm and 50 ppm at p < 0.01 . 
c - Significantly different from 0 ppm at p < 0.05 and from 50 ppm at p < 0.01. 
TABLEIV-14 
CELL-MEDIATED CYTOLOYSIS OFYAC-1 TARGET CELLS BY 
SPLENIC LYMPHOCYTES AND NON-SPECIRC KILLER 
CELLS FROM CD-I MICE EXPOSED FOR 13 WEEKS 
TO NITROUS OXIDE 
Nitrous oxide Eers::en! 51 Ct teleasea,b 
concentration 1QQ:1C 5Q:1C 25:1c 
(ppm) 
0 1786±531 1467±613 1078±125 
50 1103±271 711±237 294±233 
500 1522±323 1000±196 742±337 
5000 1717±312 861±331 728±293 
a - Data presented as the means±SE (n = 6) . 
b - Expressed as: (dpm/1 Q6 target cells minus spontaneous dpm/1 os target 
cells) X 10-2. 
c - Effector cell:target cell ratio. 
Note: Maximal 51 Cr release was measured as 5918 dpmf1QStarget cells and 
spontaneous as1490 dpm/106 target cells, both X 10·3. 
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TABLE IV-1 5 
ORGAN WEIGHTS• OF SHEEP RED BLOOD CELL-SENSITIZED CD- I 
MICEb FOLLOWING 13-WEEK EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Spleen Thymus Liver Kidneys Adrenals 
concentration (X 102) 
(ppm) 
0 0.34±0.02 0.10±0.01 5.10±0.13 1.62±0.04 0.81±0.12 
50 0.33±0.02 0.08±0.01 5.47±0.09 1.55±0.05 1.12±0.09 
500 0.32±0.03 0.10±0.01 5.26±0.06 1.60±0.09 0.81±0.14 
5000 0.33±0.02 0.08±0.01 C 5.40±0.10 1.62±0.07 0.65±0.05d 
a - Data presented as the means±SE (n = 6). Expressed as the organ weights (g)/1 00 
g body weight. 
b - Injected with sheep red blood cells ip 4 days prior to sacrifice. 
c - Significantly different from 500 ppm at p < 0.05 . 
d - Significantly different from 50 ppm at p < 0.05. 
TABLE IV-16 
HUMORAL IMMUNE RESPONSES• OF CD-I MICE FOLLOWING 13-WEEK 
EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Spleen PFCC/1 06 PFC/total 
concentration cellularityb spleen cells spleen cells 
(ppm) (X 10-3) 
0 1.20±0.11 2219±206 282.8±23.5 
50 1.31±0.08 1802±219 252.4±44.1 
500 1.09±0.11 1803±167 210.6±31.2 
5000 1.07±0.11 1277± 74d 134.0±20.6d 
a - Data presented as the means±SE (n = 4 except for 5000 ppm 
where n = 6) . 
b - Number of lymphocytes recovered/spleen X 1 O·B. 
c - Plaque forming cells. 
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FIG. IV-6. Enzyme-linked immunosorbent assay quantitation of anti-sheep 
red blood cell immunoglobulin M levels from the sera of CD-1 mice exposed to 
nitrous oxide for 13 weeks. Titers measured in absorbance units. Presented 
as the means±SE (n = 6). *5000 ppm significantly different from 500 ppm at 
I :50 dilution, p < 0.05. **5000 ppm significantly different from 0 ppm at I :50 
dilution, p < 0.01. ***5000 ppm significantly different from both 0 ppm and 
500 ppm at 1:100 dilution, p < O.Dl. 
doses. 
Endocrine Hormones 
No differences were noted in either serum conicosterone or ACTH levels 
among the NzO-dosing groups and control animals (Tab le IV-19 ). 
TABLE IV-17 
HEMATOLOGICAL PARAMETERS• FROM CD-I MICE FOLLOWING 13-WEEK 
EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Erythrocytes Hematocrit Hemoglobin Leukocytes Leukoc)'te differentials (% l 
concentration (106fmm3) (%) (g/dL) (103fmm3) Lymphocytes Neutrophils Olhersb 
{ppm) 
0 10.14±0.48 44.9±0.9 16.9±0.3 8.32±0.20 71±4 23±3 6±2 
50 10.30±0.3 t 45.3±1.0 17.8±0.4 6.44±Q.24C 59±5 36±6 4±1 
500 10.18±0.11 42.8±0.7 16.8±0.2 6.24±0.34C 73±2 22±2 5±1 
5000 10.04±0.30 44.0±0.6 16.5±0.4 6.56±Q.23C 57±3 37±4 6:L1 
a - Data presented as the means±SE (n = 6 except for luekocyte data where n = 5 for 500 ppm and 5000 ppm). 
b - Includes monocytes, eosinophils, and basophils. 




TABLE IY-1 8 
BONE MARROW CELL RESPONSES• OF CD-I MJCE FOLLOWING 
13-WEEK EXPOSURES TO NITROUS OXIDE 
Nitrous oxide Bone marrow dUdR Normalizedd 
concentration cellularityb suppression dUdR suppression 
(ppm) value (%)c value (%)c 
0 4.67±0.37 61 .3±11 .1 100.0±18.1 
50 4.86±0.94 82.0± 9.7 133.8±15.8 
500 4.90±0.16 1 03.8±1 0.4e 169.3±17.0e 
5000 5.09±0.58 125.3± 3.61 204.4± 5.91 
a - Data presented as the means±SE (n = 6). 
b - Expressed as the total number of bone marrow cells collected 
from both femurs X 10-7. 
c - Expressed as the amount of (3H]-TdR uptake after preincubation 
with deoxyuridine (dUdR) as a percentage of uptake without 
preincubation with dUdR. 
d - Normalized to 1 00% for 0 ppm values . 
e - Significantly different from 0 ppm at p < 0.05. 









·v; 200 • 0 ppm Vl <I> a. Fa 50 ppm a. 1m 500 ppm ::> 
Vl 
f.2l 5000 ppm a: 








F IG . IV-7. Deoxyuridine suppression test performed on CD-1 mouse bone 
marrow cells fol lo wing 13-week anima l exposures to nitrous oxide . Presented 
as the means:!:SE (n = 6). *Significantly different from 0 ppm. p < 0.05. 
**Significantly different fro m both 0 ppm and 50 ppm. p < 0.01. 
TABLE IV-19 
SERUM ENDOCRINE HORMONE LEVELS• IN CD-I MICE FOLLOWING 
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Body and Organ Weights 
During 2-week NzO exposures only transient differences were noted in 
animal body weights (Table lY-2), and no differences were noted during the 
13-week stud y period (Figure IY-5 ). Relative organ we ights also 
demonstrated no differences following both exposure periods (Tables IV -3 
and IY-11), with the exception of the livers. These showed transien tly 
decreased relative weights afte r 2 weeks, but the weights were s ignificantly 
lower for all three Nz 0-dosing groups compared to control mice after 13-week 
gas exposures. 
One possible explanation for the decreased liver weights at 13 weeks is 
found in studies showing that high-level (50%), usually sho rt-term, NzO 
exposures result in depressed hepatic uptake of folate (McGing et al.. 1978; 
Perry et al .. 1979). Furthermore, exposing rats to NzO leads to increased levels 
of both plasma and urinary folate (Lumb et al., 1982). As a consequence of 
both decreased folate uptake and its increased excretion. tissue stores of folate 
are markedly decreased, and this is especially true for the liver (Lumb et al., 
1980, 1981 a), the primary folate repository organ (Nunn and Chanarin, 1985). 
As this substance is necessary for DNA synthesis, its absence may be 
responsible for decreased organ ce llularity and weight. 
There is inconclusive evidence that Nz 0 exposure results in some form of 
hepatotoxicity (Brodsky, 1985). One previous subchronic study (Rice et al., 
1985), using a different mouse strain and higher Nz 0 levels for shorter (4 hr) 
daily time periods than were used in this study , revealed no liver weight 
63 
changes fo llowing gas ex po sure s. Possibl e cy tochrome P-450-mediated 
toxicity , however, has been ruled out following negative re sults from mice 
(Rice ec al.. 1985) and rats (Hallen and Johansson, 1975 as cited by Brodsky , 
1935). 
Immunologi c Assessments 
The results obtained from experiments involving ly mphoc yte 
transformation suggest that N2 0 appears to have a biphasic effect on duration 
of gas exposure . Following 2-week exposures there was a general trend 
to ward suppressed lymphoblastogenesi s , with DNA synthes is decreasing 
significantl y at the highest Nz 0 exposure level (Table IV-4). This trend was 
als:> observed in the MLC assays (Table IV-5 ). 
At the conclusion of 13-week exposures the effects were reversed. In the 
mi:ogen assays (Table IV-12) both unstimulated and PHA- and LPS-induced 
Dl\A synthesis increased in a dose-related fashion, being significantly 
elevated at 5000 ppm. In the presence of Con A and PWM, [3H]-TdR 
incorporation increased by 2X and 4X, respectively; however, s tatistical 
significance was not apparent due to the va riability observed in individual 
nunbers. As with the 2-week experiments, the results of the 13-week 
mi:ogen assays were supported by the similarity of the 13-week MLC 
fin1ings, with increased radioisotopic uptake being observed at the higher 
N zO concentrations . While the increased [3 H]-TdR uptake seen in the cells 
fron the high-dosed, subchronic animals in both the blastogenic and the 
MlC assays was unexpected, the occurrence was not without precedent. 
Das and Hoffbrand (1970), using human peripheral blood lymphocytes 
fron patients with B 12 deficiency and pernicious anemia, also found that PHA-
culured cells took up more [3 H]-TdR than did control lymphocytes that had 
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no vitamin B12 anomaly. They further noted that dUdR failed to suppress the 
uptake of the radioisotope in vitamin-deficient ce lls and suggested that [3 H]-
TdR added to the cell cultures sk irted the blocked B 12 pathway, allowing DNA 
synthesis to proceed fo llowin g activation of a sa lvage pathway catalyzed by 
thymidine kinase. This enzyme has demonstrated increased activity in the 
bone marrow cells of people deficient in vitamin Bt 2 (Nakao and Fujioka. 
1968). The mechanistic postulate of Das and Hoffbrand ( 1970) was lent 
further c redence by the finding of Haurani (1973), that PHA-stimulated 
lymphoc ytes from people with pernicious anemia have decreased 
thymidylate synthase (dTMPS ) activ it y. More recent wo rk by Haurani et a/. 
( 1984) demonstrated that in vitro N 20 ex posure of PHA-stimul ated 
lymphocytes also decreases dTMPS activity and that this is corrected by 
addition of CH3Cbl. 
The results observed here indicate that a mechanism similar to that 
proposed by Das and Hoffbrand (1970) may have been operating during the 
current experiments. If that we re true it might mean that N20 acted as a 
mitogen in the sense that it primed the CD-I ce lls for replication , that process 
ensuing once [3 H]-TdR became available to the cells by its addition to the 
culturing media. The results of this research also indicate that the commonly 
used [3H]-TdR uptake assay may not be entirely appropriate for measuring 
blastogenic responses to mitogenic substances foll owing N2 0 exposure . 
Instead, direct quantitation of cell numbers both before and after cu lturing 
with mitogenic substances may be necessary to determine whethe r those 
substances are able to induce blastogenesis following gas exposures. 
The results of the cell-mediated cytolitic (CMC) assay, in which cytotoxic 
and helper-T-lymphocyte subpopulations undoubtedly participated, 
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demonstrate no immunomodulation. The low cy tolysis observed in these 
experiments is si milar to that seen in other immunotoxicologic assessments 
using the same an imal model (Hsieh et al., 198 8; Srischuan et al .. 1987). The 
addition of mouse fi brobl as t gamma-interferon in the current ex periments 
lent no apparent assistance to natural killer-cell (N K) activity. Based upon 
these results and those by Hsieh et al . (1988) and Srischuan et al. (1987), this 
panicular animal model does not seem to be suitable for assessing NK activity. 
Humoral immunocompetency following 2 weeks of anesthetic gas exposure 
did not seem to be compromised (Table IV-8). However, the results of the 13-
week study (Table IV -16) indicate that longe r-term exposures to N2 0 may 
prove detrimental to B-cell production of antibody , inasmuch as there was a 
significant decrease in the number of PFCs in the mice after 5000 ppm of N20 
exposure compared to the nonexposed animals . The mice exposed to N20 also 
exhibited decreased circulating anti-SRBC lgM levels after 5000 ppm gas 
exposures (Figure IV -6). 
For SRBC hemolysis to occur using the PFC assay, there must be a 
cooperative interaction among antibody-secreting B lymphocytes , T-helper 
lymphocytes that produce the lymphokincs necessary for 8-cell growth and 
differentiation , and macrophages (antigen-presenting cells). Since 
macrophage function was not studied as a part of this research, the effect of 
N 20 on PFC capabilities through these cells cannot be addressed. Similarly, 
whether the gas had any disruptive influence upon the T-helper cell 
subpopulation cannot be addressed. 
The most likely explanation for the decreased PFC activity and circulating 
lgM levels seen in the current experiments, other than depressed 
macrophage and/or helper T-cell function, is the direct effect N20 has on 
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vitamin B 12 (Banks et al., 1968: Blackburn et al. , 1977) of hindering the B-
for immunoglobulin synthesis. Hall et al. lymp hocyte replication necessary 
(1981) demonstrated that human PBLs from Bt2-dcftcient patients, when 
cultured with PWM (both a B- and T-lymphocyte mitogenic factor), produced 
much less lgG and total proteins than did the lymphocytes from healthy 
patients. They furthermore demonstrated that the addition of free, active B t 2 
to the cul ture media results in increased production of both ant ibodies and 
total proteins from B 12 -deficient , but not control, ce lls. Kafetz (1985) 
reported two cases whe rein elderly patients with B t 2 deficiency had low 
immun globulin levels prior to receiving vit amin treatment. Their an tibody 
titers reverted to more normal levels following Bt2 therapy. Neither of these 
studies quantitated lymphoc yte levels o r cell ular proliferative capacities . 
Hematologic Parameters 
Disruption of the dTMPS pathway, indirect ly measured by the deoxyuridine 
suppression tes t (dUdRST) (Metz , 1984; Wickramasinghe, 1981), ap parently 
occurred in the animals' bone marrows in both a time- and dose-dependent 
fashion subsequent to N20 exposure, wi th simi lar trends being observed over 
both time periods. After 2-week exposures, dUdR fai!e.d to suppress bone 
marrow uptake of [3H]-TdR by approximately 10% in all three dosing groups 
compared to controls (Table IV -I 0). While these differences were not 
statistically significant, in humans a 10% difference in uptake of [3 H ]- T d R 
clinically distinguishes persons with megaloblastic anemia from those 
without the disease (Metz, 1984). At the end of 13-week exposures, the effect 
was more pronounced, with dUdR suppress ion of [3H]-TdR uptake at the 
highest dose doubling that seen at 0 ppm (a 100% difference in normalized 
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val ues) (Table IV -18). These results resemble similar time- and dose-response 
patterns previously reported fo r rats (Deacon et at.. 1980b). 
Of note are the absolute (non-normalized) dUdRST values obtained in these 
studies, which we re higher than those obse rved previously in rat (B aden e t 
a/., 1983; Deacon et a/., 1979, 1980b; Nunn et a/., 1982) and human (Metz. 1984; 
Town et a/., 1986: Wintrobe. 19Rl) models despite using a similar protocol. 
Nevertheless, the differences between th e absolute va lues for c ells 
displaying dUdR-depressed [3 H]-TdR uptake and those wi th less depressed 
uptake we re comparable to those seen in studies wi th rats (McKenna et a/ ., 
1980). No studies were found in which a dUdRS T was performed on mouse 
bone marrow cells fo r comparison. 
It was thought that perhaps the dUdR concentration (0.1 llmol/ml) used in 
this study was too low to suppress ce llular radioisotopic uptake, but 
experimental observations using 10- and 100-fold higher dUdR 
concentrations, conducted prior to performing this study (results not shown 
or published), produced similar results. One study (McKenna et a/., 1980) 
indicated that rat bone marrow cells preincubated wi th varied 
concentrations of dUdR prior to [3H]-TdR treatment responded by produc ing a 
wide range of dUdR suppresion values, from near 0% to near 100%. This 
study (McKenna et a/. , 1980) also demonstrated that regardless of the dUdR 
concentration utilized, the differences in dUdRST values obtained ran 
parallel when comparing normal cells to those with vitamin B12 deficiencies. 
The subchronic study by Rice et a/. (1985) differed from the subchronic 
results of this study in that they reponed no change in total peripheral blood 
leukocyte numbers when using Swiss Webster mice, despite the use of high 
N zO exposure concentrations (5000 ppm 10 500,000 ppm). The CD-1 mice used 
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in this study had markedly (p < 0.01) fewer leukocytes/mm3 of blood than did 
their nondosed counterparts. However, based upon othe r NzO-hematologic 
studies of varying nature (usually higher dose and shorter term) (Green and 
Eastwood, 1963; Kripke er a/., 1977), the leukopenia noted in this study was not 
at all unexpected. Coupled with the decreased DNA synthesis noted in both 
unstimulated or mitogen-stimulated lymphocytes, the observed significant 
leukopenia in the current experiments may indicate that seve re 
compromise of immune function is possible at higher levels of Nz 0 exposure 
over subchronic periods of time. 
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CHAPTER VI 
CONCLUSIONS AND RECOMMENDATIONS 
This research has demonstrated that in a mouse model NzO, at exposure 
levels to which humans may be exposed and for time periods which mimic 
occupational settings , may be immunotoxic ; although consistent, significant 
eff ects were observed only at 5000 ppm, with no change at 50 ppm and 
occasional changes at 500 ppm. It is not ce rtain whether there is a cell-
mediated immune (CMI) effect or not, but it appears that NzO may suppress 
antibody-mediated immunity (AMI). Nitrous ox ide probably has no effect on 
non s pecific immunocompetency, but this animal model may not be 
appropriate for making such a determination. Whether the effect of NzO 
upon immune system cells is direct or is the result of bone marrow 
suppression or both cannot be determined from these results, although the 
possibility of the latter occurrence seems most likely. There appears to be no 
effect upon c irculating hormone levels following gas exposure. 
Because of the variable results at the lower gas-exposure levels , it seems 
that Nz 0 at or below 50 ppm may be devoid of immunotoxic properties even 
after 13 weeks of exposure. These low levels of NzO exposure are routinely 
observed in well-scavenged hospital operatories but are less often achieved 
in unscavenged hospital operatories or in dental operatories . There should, 
therefore, be some concern regarding Nz O's immunotoxicologic potential for 
personnel exposed to the gas in the latter situations. It should also be 
considered that occupational exposures to Nz 0 may last for longer periods of 
time (years) than were observed in these experiments. Such human 
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exposure s may also represe nt a greater proportion of a person 's life span 
(perhaps as much as 30 years o r 40% for career anesthesiologists) than were 
obse rved in the CD-I mice (a pproximately 15% of their life expec tancy). 
Converse ly, most human exposures arc not expec ted to be as continuous as the 
ex posure regimens used in these experiments, which would allow fo r longer 
and more frequent recovery periods from gas exposures. 
Several recommendations seem appropriate based upon these results. 
First, the use of an outbred s train of mouse resulted in a large amount of 
intragroup va riation . This perhaps masked N2 0 exposure effect s that 
otherwi se might have been apparent. It is therefore recommended that any 
further immunotoxicologic research with this gas (o r any o ther potenti a lly 
immunotoxic substance, for that matter) be performed with inbred animal 
strains. Second, since there is evidence that N2 0 is potentially immunotoxic, 
especially with regard to AMI, it is suggested that further immunotoxicologic 
assessment be performed to determine if there is a gas effect. This would 
include the performance of bacterial o r viral antigenic challenge assays, 
macrophage-function assessment, T- and B-lymphocyte enumeration , an d so 
on. These assays may better delineate whether N2 0 has an effect upon CMI. 
Third, if further immunotoxicologic testing is performed, the use of an 
animal model that better demonstrates non-specific immune responsiveness 
should be considered. Last, in addition to performing further 
immunotoxicologic tests, it may be desireable to perform dUdRSTs on 
lymphoid cells as well as bone marrow cells to better determine their DNA 
synthetic capabilities. Such studies performed in the presence and absence 
of exogenous vitamin B12· folinic acid, and/or methyltetrahydrofolic acid may 
help to define the mechanistic immunotoxicity of N20. 
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a - The observations are based upon approximately 295 readings 
taken 4 times daily throughout the exposure periods. Measure-
ments of nitrous oxide concentrations were taken at the level of 
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FIG . B-1. Calibration curve utilized for determining infrared analyzer 
absorbance re adin g versus inhalation chamber nitrous ox ide concentration. 
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